锥形束CT肺动脉造影在慢性血栓栓塞性肺动脉高压球囊肺动脉成形术项目启动期的应用
单中心单臂前瞻性研究纳入19例慢性血栓栓塞性肺动脉高压患者,2017至2022年行90次锥形束CT肺动脉造影引导下球囊肺动脉成形术,术后平均肺动脉压、肺血管阻力、NYHA-FC I-II比例及NT-proBNP均显著改善,总不良事件率14.4%,主要不良事件率7.7%,无围术期死亡。
要点
- 锥形束CT肺动脉造影用于三维血管测绘和精准病灶靶向,可显示远端血栓栓塞病变并提供实时引导。
- 术后mPAP中位数37.0 mmHg降至25.5 mmHg,PVR中位数5.5 Wood单位降至3.3 Wood单位,均P<0.001。
- 总不良事件率14.4%,主要不良事件率7.7%(均为CIRSE 3级),咯血率4.4%,无围术期死亡。
核心结论
- 在项目启动期,锥形束CT肺动脉造影引导下球囊肺动脉成形术似乎是一种有效且安全的方法,有助于取得与成熟中心相似的结果。
研究设计与样本
- 单中心、单臂、前瞻性研究,2017至2022年纳入19例慢性血栓栓塞性肺动脉高压患者,共行90次球囊肺动脉成形术,采用锥形束CT肺动脉造影进行三维血管测绘和精准病灶靶向。
诊断标准与关键数值
- 术前mPAP中位数37.0 mmHg(IQR 28.0-46.0)vs术后25.5 mmHg(IQR 22.8-31.5),P<0.001。
- 术前PVR中位数5.5 Wood单位(IQR 3.4-8.5)vs术后3.3 Wood单位(IQR 2.7-4.6),P<0.001。
- 术前NYHA-FC I-II比例8例(42%)vs术后18例(94%),P=0.04。
- 术前NT-proBNP中位数165 pg/mL(IQR 82-1146)vs术后127.0 pg/mL(IQR 57-216),P=0.014。
- 总不良事件率14.4%,主要不良事件率7.7%(均为CIRSE 3级),咯血率4.4%,无围术期死亡。
临床应用与阅片要点
- 锥形束CT肺动脉造影可显示远端血栓栓塞病变并提供实时引导,用于三维血管测绘和精准病灶靶向。
- 作者认为在项目启动期该引导方式似乎有效且安全,有助于取得与成熟中心相似的结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Cone beam CT pulmonary angiography (CBCT-PA) has proven to be a valuable technique during balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH) in established centres. This study aimed to demonstrate the safety and efficacy of CBCT-PA-guided BPA for CTEPH during the initial period of a BPA program. CBCT-PA improves procedural accuracy by visualising distal thromboembolic lesions and providing real-time guidance, which is critical during program initiation.
MATERIALS AND METHODS: This single-centre, single-arm study prospectively evaluated patients with CTEPH undergoing BPA from 2017 to 2022. Outcomes of interest included pre-BPA and post-BPA 6-minute walking distance, New York Heart Association Functional Classification (NYHA-FC), mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), N-terminal pro B-type natriuretic peptide (NT-proBNP), and BPA-related adverse events (AEs). Statistical analysis compared pre-BPA and post-BPA results. CBCT-PA was used for three-dimensional (3D) vascular mapping and precise lesion targeting.
RESULTS: Ninety BPA sessions were performed on 19 patients under CBCT-PA guidance. Significant improvements were observed in mPAP (37.0 mmHg [interquartile range (IQR): 28.0-46.0] vs 25.5 [IQR: 22.8-31.5]; P<0.001), PVR (5.5 Wood units [IQR: 3.4-8.5] vs 3.3 [IQR: 2.7-4.6]; P < 0.001), NYHA-FC I-II rate (8 [42%] vs 18 [94%]; P = 0.04), and NT-proBNP (165 pg/mL [IQR: 82-1146] vs 127.0 [IQR: 57-216]; P = 0.014). Overall AE rate was 14.4%, and major AE rate was 7.7% (all Cardiovascular and Interventional Radiology Society of Europe [CIRSE] grade 3). The haemoptysis rate was 4.4%. No periprocedural deaths were reported.
CONCLUSION: BPA performed under CBCT-PA guidance appeared to be an effective and safe approach in the program's initial period, helping achieving similar results as established centres.
引用
- Páez-Carpio A, Zarco FX, Serrano E, et al. Cone beam CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension during the program initiation period. Clin Radiol. 2025. PMID: 40058193. doi:10.1016/j.crad.2025.106847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。